MNKD
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- MannKind receives FDA approval for Furoscix ReadyFlow, the first autoinjector delivering IV-equivalent diuretic therapyJul 24, 2026
- MannKind received a breakthrough T1D grant to support the pediatric INHALE-1ST trial of AfrezzaJun 24, 2026
- MannKind completed randomization in the Phase 1b INFLO-1 study and enrolled the first patient in the Phase 2 INFLO-2 trialJun 3, 2026
- MannKind enrolled the first patient in the INHALE-1ST pediatric study evaluating Afrezza for newly diagnosed type 1 diabetesFeb 9, 2026
- MannKind received FDA approval for updated Afrezza label with MDI/pump switching guidanceJan 27, 2026